Please upgrade your Flash Player Tagged in: Access to health care, Administrative fees, Administrative procedure, Administrative remedies, Agriculture, Animals, Antibiotics, Aquaculture, Authorization, Authors and authorship, Budgets, Business, Child health, Children, Civil liberties, Clinical trials, Communicable diseases, Communication in medicine, Communication in science, Communications, Conflict of interests, Congress, Congressional investigations, Congressional reporting requirements, Consumer education, Consumers, Cosmetics, Criminal justice, Criminal justice information, Data banks, Deceptive advertising, Department of Health and Human Services, Direct mail advertising, Directories, Drug advertising, Drug approvals, Drug industry, Drug resistance in microorganisms, Drugs, Electronic data interchange, Electronic government information, Emergency communication systems, Emergency management, Employee training, Environmental assessment, Environmental protection, Executive departments, Executive reorganization, Eye diseases, Federal advisory bodies, Federal employees, Federal officials, Federal preemption, Financial disclosure, Fines (Penalties), Food and Drug Administration (FDA), Food labeling, Food safety, Foundations, Fund raising, Generic drugs, Genetic engineering, Genetic research, Gifts, Government employees, Government information, Government paperwork, Government publicity, Grants-in-aid, Hazardous substances, Health information systems, Health policy, Health surveys, Humanities, Identification devices, Imports, Intellectual property, Internet, Inventors, Job training, Labeling, Law, Local laws, Medical associations, Medical care, Medical ethics, Medical instruments and apparatus, Medical supplies, Medicine, Nonprofit organizations, Nosocomial infections, Orphan drugs, Patents, Pediatrics, Peer review organizations (Medicine), Performance measurement, Pesticides, Pharmaceutical research, Physicians, Product counterfeiting, Product development, Product safety, Public contracts, Public meetings, Public-private partnerships, Radioisotopes in medicine, Research and development, Research grants, Right of privacy, Risk, Science policy, Scientists in government, Seafood, Skin cancer, Small business, Social services, Standards, State and local government, State laws, Technology, Telecommunication, Television advertising, Terrorism, Trade, Trade agreements, Trade negotiations, User charges, Veterinary medicine, Warning labels
Latest Update: Friday, August, 29th 2008
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, to enhance the postmarket authorities of the Food and Drug Administration with respect to the safety of drugs, and for other purposes. 9/27/2007--Public Law. (There is 1 other summary) (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)Food and Drug Administration Amendments Act of 2007 - Title I: Prescription Drug User Fee Amendments of 2007 - (Sec. 101) Prescription Drug User Fee Amendments of 2007 - (Sec. 102) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to include postmarket safety activities within the process for the review of human drug applications or supplements, including: (1) developing and using improved adverse event data collection systems and improved analytical tools to assess potential [...] show full description
- 09/27/2007 - Signed by President.
- 09/27/2007 - Became Public Law No: 110-85.
- 09/26/2007 - Presented to President.
- 09/21/2007 - Message on Senate action sent to the House.
- 09/20/2007 - Cleared for White House.
show all actions- 09/27/2007 - Signed by President.
- 09/27/2007 - Became Public Law No: 110-85.
- 09/26/2007 - Presented to President.
- 09/21/2007 - Message on Senate action sent to the House.
- 09/20/2007 - Cleared for White House.
- 09/20/2007 - Passed Senate without amendment by Unanimous Consent. (consideration: CR S11831-11841)
- 09/19/2007 - DEBATE - The House proceeded with forty minutes of debate on H.R. 3580.
- 09/19/2007 - Referred to the House Committee on Energy and Commerce.
- 09/19/2007 - Mr. Dingell moved to suspend the rules and pass the bill.
- 09/19/2007 - Considered under suspension of the rules. (consideration: CR H10551-10599)
- 09/19/2007 - On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 405 - 7 (Roll no. 885). (text: CR H10551-10594)
- 09/19/2007 - Motion to reconsider laid on the table Agreed to without objection.
- 09/19/2007 - Received in the Senate.
- 09/19/2007 - Received in the Senate, read twice.
show latest actions
|
Important People
Latest News
Searching for articles...
|
